Latest Insider Transactions at Evolent Health, Inc. (EVH)
This section provides a real-time view of insider transactions for Evolent Health, Inc. (EVH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Evolent Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Evolent Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 02
2021
|
Steve Tutewohl Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,956
-2.54%
|
$136,988
$23.02 P/Share
|
|
Aug 02
2021
|
Steve Tutewohl Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,956
+2.48%
|
$95,296
$16.1 P/Share
|
|
Jul 30
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
3,502
-0.26%
|
$80,546
$23.0 P/Share
|
|
Jul 30
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,901
+0.29%
|
$5,703
$3.84 P/Share
|
|
Jul 19
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.48%
|
$420,000
$21.6 P/Share
|
|
Jul 19
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.45%
|
$30,000
$3.84 P/Share
|
|
Jul 09
2021
|
Steve Tutewohl Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,849
-3.77%
|
$304,678
$22.84 P/Share
|
|
Jul 09
2021
|
Steve Tutewohl Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,849
+3.54%
|
$207,735
$15.16 P/Share
|
|
Jul 09
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
7,168
-0.53%
|
$164,864
$23.0 P/Share
|
|
Jul 09
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,584
+0.53%
|
$10,752
$3.84 P/Share
|
|
Jul 08
2021
|
Steve Tutewohl Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
200
-0.18%
|
$4,400
$22.0 P/Share
|
|
Jul 08
2021
|
Steve Tutewohl Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.17%
|
$2,600
$13.29 P/Share
|
|
Jul 01
2021
|
Steve Tutewohl Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,352
-7.58%
|
$196,392
$21.05 P/Share
|
|
Jul 01
2021
|
Steve Tutewohl Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,352
+7.04%
|
$65,464
$7.83 P/Share
|
|
Jun 17
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.52%
|
$380,000
$19.7 P/Share
|
|
Jun 17
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.5%
|
$30,000
$3.84 P/Share
|
|
Jun 11
2021
|
Cheryl Scott Director |
SELL
Open market or private sale
|
Direct |
6,405
-11.64%
|
$121,695
$19.39 P/Share
|
|
Jun 10
2021
|
Mary Bridget Duffy Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+12.94%
|
-
|
|
Jun 10
2021
|
David Farner Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+11.23%
|
-
|
|
Jun 10
2021
|
Cheryl Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+12.39%
|
-
|
|
Jun 10
2021
|
Diane Holder Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+11.23%
|
-
|
|
Jun 10
2021
|
Peter J Grua Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+19.92%
|
-
|
|
Jun 10
2021
|
Michael D'Amato Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+7.69%
|
-
|
|
Jun 10
2021
|
Kim Keck Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+42.21%
|
-
|
|
Jun 10
2021
|
Craig A. Barbarosh Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+40.09%
|
-
|
|
Jun 10
2021
|
Frank J Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+1.17%
|
-
|
|
May 17
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.5%
|
$380,000
$19.73 P/Share
|
|
May 17
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.47%
|
$30,000
$3.84 P/Share
|
|
May 04
2021
|
Jonathan Weinberg General Counsel |
SELL
Open market or private sale
|
Direct |
20,000
-17.89%
|
$420,000
$21.37 P/Share
|
|
May 04
2021
|
Jonathan Weinberg General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+15.18%
|
$60,000
$3.84 P/Share
|
|
May 03
2021
|
Steve Tutewohl Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
19,295
-7.8%
|
$405,195
$21.49 P/Share
|
|
May 03
2021
|
Steve Tutewohl Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,352
+7.04%
|
$65,464
$7.83 P/Share
|
|
Mar 01
2021
|
Seth Blackley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,866
+18.62%
|
-
|
|
Mar 01
2021
|
Jonathan Weinberg General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+21.41%
|
-
|
|
Mar 01
2021
|
John Paul Johnson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+22.61%
|
-
|
|
Mar 01
2021
|
Steve Tutewohl Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+19.99%
|
-
|
|
Mar 01
2021
|
Aammaad Shams Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Feb 01
2021
|
Kim Keck Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+50.0%
|
-
|
|
Jan 04
2021
|
Craig A. Barbarosh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,849
+50.0%
|
-
|
|
Jun 01
2018
|
Unitedhealth Group Inc Director |
SELL
Open market or private sale
|
Indirect |
2,861,065
-100.0%
|
$54,360,235
$19.23 P/Share
|
|
Mar 05
2018
|
Unitedhealth Group Inc Director |
BUY
Conversion of derivative security
|
Indirect |
1,772,898
+38.26%
|
-
|
|
Mar 01
2018
|
Unitedhealth Group Inc Director |
SELL
Open market or private sale
|
Indirect |
3,040,000
-73.64%
|
$39,520,000
$13.7 P/Share
|